APA (7th ed.) Citation

Metzger1., O., Mandrekar, S., Goel, S., Gligorov, J., Lim, E., Ciruelos, E., . . . Prat, A. (2026). Palbociclib for Hormone-Receptor-Positive, HER2-Positive Advanced Breast Cancer. New England Journal of Medicine, 394(5), 451. https://doi.org/10.1056/NEJMoa2511218

Chicago Style (17th ed.) Citation

Metzger1., O., et al. "Palbociclib for Hormone-Receptor-Positive, HER2-Positive Advanced Breast Cancer." New England Journal of Medicine 394, no. 5 (2026): 451. https://doi.org/10.1056/NEJMoa2511218.

MLA (9th ed.) Citation

Metzger1., O., et al. "Palbociclib for Hormone-Receptor-Positive, HER2-Positive Advanced Breast Cancer." New England Journal of Medicine, vol. 394, no. 5, 2026, p. 451, https://doi.org/10.1056/NEJMoa2511218.